these successes , the availability of techniques that permit early identification and localization of gastrinomas , and the advent of h2-receptor antagonists that can control gastric hypersecretion without gastrectomy must be considered in managing patients with gastrinomas .
C0038351
gastric
C0017118
gastrectomy